A real-world disproportionality analysis of cyclosporine from the FDA Adverse Event Reporting System (FAERS) database
Cyclosporine is an immunosuppressant used to prevent organ rejection in kidney, liver, and heart allogeneic transplants.This study aimed to assess the safety of cyclosporine through the analysis of adverse events (AEs) related to cyclosporine in the US Food and Drug Administration Adverse Event Reporting System (FAERS).To detect AEs associated with